BSECompany Update3 Aug 2026 · 3 Aug 2026, 06:34 pm

Intimation of schedule for Q1FY27 Earnings Conference Call

Marksans Pharma Ltd · 524404

✦ AI SummaryResults

Marksans Pharma Ltd has scheduled a conference call on August 13, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

d4568dc5-5580-48c3-b27b-5cda6d1eaf83.pdf

pdf

Download →
View document text
August 03, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai – 400001. Bandra (East), Mumbai – 400051. Scrip Code: 524404 Symbol: MARKSANS Subject: Intimation of schedule for Q1FY27 Earnings Conference Call Dear Sir/Madam, Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled a conference call for analysts and investors on Thursday, August 13, 2026 at 04:30 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026. The details and schedule with respect to the conference call is enclosed herewith. The presentation along with the audio recording of the call and the transcript will be hosted on the Company’s website at https://www.marksanspharma.com/earnings-call-transcripts.html We request you to take the aforesaid on your records. Thanking you. Yours faithfully, For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Encl: As below Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com Marksans Pharma Ltd Q1FY27 Earnings Call Thursday, 13 August 2026 at 16:30 hrs (IST) CIN: L24110MH1992PLC066364 DAM Capital Advisors Ltd invites you to Marksans Pharma Ltd’s post results conference call Marksans Pharma Ltd’s Management Speakers Mr. Mark Saldanha – Founder, Chairman and Managing Director Mr. Jitendra Sharma – Chief Financial Officer Call Leaders Nitin Agarwal – Analyst, DAM Capital Advisors Ltd Dial-in Details Universal access: +91 22 6280 1384, +91 22 7115 8285 (accessible from all networks and countries) Diamond passcode link: click here International dial-in Hong Kong Singapore UK USA 19:00 (HKT) 19:00 (SGT) 12:00 PM (BST) 07:00 (EDT) Toll free 800964448 8001012045 08081011573 18667462133 *Please dial-in at least 5-10 minutes prior to the schedule to get connected to the call in time For further information please contact Nitin Agarwal / Payal Shah DAM Capital Advisors Limited : +91 22 4202 2568 / 2638  nitin.a@damcapital.in / payal@damcapital.in